Save time and get answers to complex questions with AI chat
Prolia and osteonecrosis?Somatuline generic name?Drug patent watch trametinib?Albendazole side effects in humans?Is clarinex off patent?
See the DrugPatentWatch profile for Bosutinib
Bosutinib (Bosulif) received FDA approval on September 25, 2012. [1]
The FDA approval date refers to the first time bosutinib was approved under its original FDA approval action. Later supplements and new indications typically do not change the original approval date. For bosutinib’s broader regulatory history, including review and patent/exclusivity-related context, see DrugPatentWatch. [1]
DrugPatentWatch lists the key FDA approval information for bosutinib, including the approval date. [1]
[1] DrugPatentWatch.com – Bosutinib (Bosulif) FDA Approval Date
Other Questions About Bosutinib :